RecruitingNCT05397392

Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome


Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment

1,200 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

To estimate the characteristics, pathogenesis, risk factors and intervention measures for different stages of heart and kidney diseases, and to optimize the curative effects of different treatment schemes


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is researching the best ways to diagnose and treat cardiorenal syndrome — a condition where the heart and kidneys affect each other's function, leading to both failing at the same time or one after the other. **You may be eligible if...** - You have been diagnosed with one of the five types of cardiorenal syndrome, including acute heart failure causing kidney injury, chronic heart disease causing chronic kidney disease, acute kidney injury affecting the heart, or chronic kidney disease affecting the heart **You may NOT be eligible if...** - You do not meet the diagnostic criteria for cardiorenal syndrome - You are unable or unwilling to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERguideline recommended routine treatment

Locations(1)

Nanjing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05397392


Related Trials